Ultimately money can overcome almost any obstacle, but Hepalink's position, and to a certain extent that of Eastern (they're around 20% I believe)...I think it complicates issues, plus you have Royalty Preferred Shares held by Zenith. I believe it would make Resverlogix and/or just Apabetalone a very convoluted acquisition.
It should be noted, in case you're not aware...Eastern Capital, that's actually Kenneth Dart of the Dart Container fortune, he has a net worth estimated at over $6 billion. Eastern is simply his investment company.
I've long considered the most likely deal to be one where Shenzhen Hepalink takes Resverlogix over and maybe even uses an acquisition as an entry to the North American capital markets. Still, even while I think its 'most likely' I also see the share structure and ownership situation to be more than a little problematic, but just a bit less so if Hepa was doing the acquiring.
If you want to taste the fruit, you have to go out on a limb. But if you wait for the herd to move out on the limb....the branch tends to snap.
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM